cis-2-Methoxycyclopentamine

Catalog No. :
ACQHIA091
CAS No. :
1431506-53-4
Molecular Formula :
C6H13NO
Molecular Weight :
115.18

IUPAC Name:(1R,2S)-2-methoxycyclopentan-1-amine

cis-2-Methoxycyclopentamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$570.00Login to see priceIn stockInquiry
250mg95%$950.00Login to see priceIn stockInquiry
500mg95%$1591.00Login to see priceIn stockInquiry
1g95%$2375.00Login to see priceIn stockInquiry
5g95%$9444.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-2-Methoxycyclopentamine
IUPAC Name(1R,2S)-2-methoxycyclopentan-1-amine
MDL No.MFCD28501309
Molecular FormulaC6H13NO
Molecular Weight115.18
SMILESN[C@H]1[C@@H](OC)CCC1
InChI KeyPRXWOOCEFBBQCR-RITPCOANSA-N
Synonym1932461-15-8 | (1S,2R)-2-Methoxycyclopentan-1-amine | rel-(1R,2S)-2-methoxycyclopentan-1-amine | cis-2-methoxycyclopentamine | 1431506-53-4 | (1S,2R)-2-Methoxy-cyclopentylamine | cis-2-Methoxy-cyclopentylamine | SCHEMBL23966438 | rac-(1R,2S)-2-methoxycycl
CAS No.1431506-53-4
PubChem CID28112903

Safety Data

Pictogram
FlammableCorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H226-H302-H314-H335
Precautionary Statement(s)
P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACQHIA091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQHIA091 route product structure diagram
    ACQHIA0911431506-53-4 In Stock
Inquiry

2. ACQHIA091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQHIA091 route product structure diagram
    ACQHIA0911431506-53-4 In Stock
Inquiry

Comments (0)